Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2024Journal of Cardiology & Cardiovascular TherapyOpen Access

Understanding Cardiomyopathy Induced by Doxorubicin Therapy: Mechanisms, Diagnosis, and Management Strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMaria Isabel Gomez Coral

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maria Isabel Gomez Coral (2024) studied this question.

synapsesocial.com/papers/68e6bbccb6db64358763c39bhttps://doi.org/10.19080/jocct.2024.19.556012
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy2022 · 31 citations
  2. 2Cardioprotective interventions for cancer patients receiving anthracyclines2011 · 556 citations
  3. 3Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy2021 · 113 citations
  4. 4Cardiac ultrastructural changes induced by daunorubicin therapy1973 · 207 citations
  5. 5Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway2021 · 22 citations